Taken together, CASC11 silencing remarkably abated the malignancy of HCC cells in vitro by powerfully negatively impacting HCC cell proliferation, migration, invasion, and glucose metabolism and enhancing apoptosis, indicating that CASC11 would be an important oncogene for HCC progression. Here, CASC11 is linked to hepatocellular carcinoma.